Repeated 5-day cycles of low dose aldesleukin in amyotrophic lateral sclerosis (IMODALS): A phase 2a randomised, double-blind, placebo-controlled trial
William Camu, Gilbert Bensimon(Pitié-Salpêtrière Hospital), Christophe Masseguin(Centre Hospitalier Universitaire de Nîmes), Carey Suehs(Université de Montpellier), Ammar Al‐Chalabi(King's College London), Marius Mickunas(King's College London), Cecília Garlanda(Humanitas University), Ulf Andréasson(Sahlgrenska University Hospital), Timothy Tree(King's College London), John De Vos(Inserm), Andrea Malaspina(University College London), Raúl Juntas‐Morales(Université de Montpellier), Henrik Zetterberg(University of Wisconsin–Madison), Janine Kirby(University of Sheffield), Pamela J. Shaw(University of Sheffield), P. Nigel Leigh, Christine Payan(Sorbonne Université), Jean‐Luc Veyrune(Université de Montpellier), Safa Saker(Genethon (France)), Nicolas Pageot(Université de Montpellier), Massimo Locati(Humanitas University)
Cited by 81
Related Papers
The chemokine system in diverse forms of macrophage activation and polarization
|Trends in Immunology|2004|6.5k
Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
|Trends in Immunology|2002|5.5k
Macrophage plasticity and polarization in tissue repair and remodelling
|The Journal of Pathology|2012|2.4k
Transcriptional Profiling of the Human Monocyte-to-Macrophage Differentiation and Polarization: New Molecules and Patterns of Gene Expression
|The Journal of Immunology|2006|2.3k